GO
Loading...

Pfizer Inc

More

  • Early Glance: Pharmaceuticals companies Thursday, 19 Mar 2015 | 10:22 AM ET

    Baxter International Inc. fell$. 38 or. 6 percent, to $68.17. Bristol-Myers Squibb Co. fell$. 13 or. 2 percent, to $68.34. Eli Lilly& Co. fell$. 58 or. 8 percent, to $72.96.

  • Stocks need clarity on the tightening cycle Thursday, 19 Mar 2015 | 10:06 AM ET
    The Federal Reserve Building in Washington, D.C.

    Equities tend to gain in the period leading into interest rate tightening cycles, then reverse when the tightening begins.

  • TRENTON, N.J.— A huge study of Pfizer's blockbuster vaccine against pneumonia and other bacterial infections in adults 65 and older found it protected most of them against dangerous infections in the bloodstream and other sterile body areas. Overall, Prevnar reduced community-acquired pneumococcal infections— those contracted outside of hospitals and...

  • Most active New York Stock Exchange-traded stocks Wednesday, 18 Mar 2015 | 2:23 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at 1 p.m.:. AT&T Inc. fell. 5 percent to $32.75 with 11,356,100 shares traded. Alcoa Inc. fell. 1 percent to $13.05 with 22,015,700 shares traded.

  • Midday Glance: Pharmaceuticals companies Wednesday, 18 Mar 2015 | 2:23 PM ET

    Baxter International Inc. fell$. 81 or 1.2 percent, to $67.66. Bristol-Myers Squibb Co. fell$. 46 or. 7 percent, to $67.17. Eli Lilly& Co. rose$. 41 or. 6 percent, to $71.25.

  • Early Glance: Pharmaceuticals companies Wednesday, 18 Mar 2015 | 11:37 AM ET

    Baxter International Inc. fell$. 21 or. 3 percent, to $68.26. Bristol-Myers Squibb Co. fell$. 22 or. 3 percent, to $67.40. Eli Lilly& Co. rose$. 42 or. 6 percent, to $71.26.

  • Final Glance: Pharmaceuticals companies Tuesday, 17 Mar 2015 | 6:16 PM ET

    Baxter International Inc. rose$. 04 or. 1 percent, to $68.47. Bristol-Myers Squibb Co. fell$. 41 or. 6 percent, to $67.62. Eli Lilly& Co. fell$. 23 or. 3 percent, to $70.84.

  • Cramer: These trends are wreaking havoc right now Tuesday, 17 Mar 2015 | 6:12 PM ET
    A trader works on the floor of the New York Stock Exchange.

    Jim Cramer is seeing tons of inconsistency in the market right now. He no longer is trusting the trends that have made fortunes before.

  • Most active New York Stock Exchange-traded stocks Tuesday, 17 Mar 2015 | 2:32 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. AT&T Inc. fell. 5 percent to $32.90 with 23,704,000 shares traded. Alcoa Inc. fell 1.7 percent to $13.06 with 28,655,800 shares traded.

  • Midday Glance: Pharmaceuticals companies Tuesday, 17 Mar 2015 | 2:32 PM ET

    Baxter International Inc. rose$. 26 or. 4 percent, to $68.69. Bristol-Myers Squibb Co. fell$. 54 or. 8 percent, to $67.50. Eli Lilly& Co. fell$. 36 or. 5 percent, to $70.71.

  • Early Glance: Pharmaceuticals companies Tuesday, 17 Mar 2015 | 10:28 AM ET

    Baxter International Inc. fell$. 21 or. 3 percent, to $68.22. Bristol-Myers Squibb Co. fell$. 46 or. 7 percent, to $67.57. Eli Lilly& Co. fell$. 16 or. 2 percent, to $70.91.

  • This is what currency swing cost US companies in 4Q Tuesday, 17 Mar 2015 | 7:33 AM ET
    A clerk handles dollars and euros at a money exchange office in Paris.

    Foreign exchange swings cost North American corporates $18.66 billion in revenue in the fourth quarter, according to a report.

  • *Backers include British govt, GSK, J&J, Pfizer, Lilly, Biogen. Drug companies involved include GlaxoSmithKline, Johnson& Johnson, Eli Lilly, Pfizer and Biogen Idec. The initiative, announced by Britain's health minister Jeremy Hunt at a meeting in Geneva on Tuesday, follows a Group of Eight nations conference in London in December 2013 that set a goal of finding a...

  • TRENTON, N.J.— Major drugmakers, the British government and a top Alzheimer's research charity are pooling more than $100 million to create a global fund to accelerate efforts to find a treatment or even a cure for the mind-robbing disease within a decade. Jeremy Hunt, the UK health secretary, was to announce the new fund Tuesday in Geneva at the World Health...

  • LONDON, March 17- The world's first venture capital fund dedicated to finding new ways to prevent and treat dementia has raised $100 million with the backing of the British government and several of the world's leading drugmakers. Drug companies involved include GlaxoSmithKline, Johnson& Johnson, Eli Lilly, Pfizer and Biogen Idec. The initiative, announced by...

  • March 17- Foreign exchange swings cost North American corporates $18.66 billion in revenue in the fourth quarter, according to a report by currency risk management consulting firm FiREapps. A slew of U.S. multinational companies, from DuPont to Procter& Gamble, have showed that a strong U.S. dollar hurt their earnings, and several blue-chip exporters said the...

  • Final Glance: Pharmaceuticals companies Monday, 16 Mar 2015 | 6:03 PM ET

    Baxter International Inc. rose $1.07 or 1.6 percent, to $68.43. Bristol-Myers Squibb Co. rose $1.16 or 1.7 percent, to $68.03. Eli Lilly& Co. rose $1.18 or 1.7 percent, to $71.07.

  • Midday Glance: Pharmaceuticals companies Monday, 16 Mar 2015 | 1:19 PM ET

    Baxter International Inc. rose$. 74 or 1.1 percent, to $68.10. Bristol-Myers Squibb Co. rose $1.03 or 1.5 percent, to $67.90. Eli Lilly& Co. rose $1.34 or 1.9 percent, to $71.23.

  • Most active New York Stock Exchange-traded stocks Monday, 16 Mar 2015 | 1:19 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. AT&T Inc. rose. 9 percent to $33.06 with 20,201,600 shares traded. Alcoa Inc. fell 2.1 percent to $13.29 with 29,622,700 shares traded.

  • Early Glance: Pharmaceuticals companies Monday, 16 Mar 2015 | 10:34 AM ET

    Baxter International Inc. rose$. 93 or 1.4 percent, to $68.29. Bristol-Myers Squibb Co. rose$. 87 or 1.3 percent, to $67.74. Eli Lilly& Co. rose $1.14 or 1.6 percent, to $71.03.